Latest news
HR-Positive Breast Cancer: Differentiating Oral SERDs and Real-World Decision-Making - AJMCAJMC · Fri, 07 Aug 2026 12:25:40 GMTVepdegestrant (Veppanu) Approved by FDA - Breast Cancer.orgBreast Cancer.org · Tue, 04 Aug 2026 07:00:00 GMTEvexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer - Via TTVia TT · Tue, 04 Aug 2026 07:00:00 GMTHR-Positive Breast Cancer: Adjuvant Oral SERDs and Implications for Clinical Practice - AJMCAJMC · Fri, 31 Jul 2026 12:13:37 GMTHR-Positive Breast Cancer: Sequencing Challenges and Future Treatment Strategies with Oral SERDs - AJMCAJMC · Fri, 31 Jul 2026 12:13:04 GMT